Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis

This publication has 28 references indexed in Scilit:

• The Influence of Remaining Live BCG Organisms in Vaccinated Mice on the Maintenance of Immunity to Tuberculosis
  Scandinavian Journal of Immunology, 2004
• Vaccination of cattle against Mycobacterium bovis
  Tuberculosis, 2001
• Wildlife disease reservoirs: the epidemiology of Mycobacterium bovis infection in the European badger (Meles meles) and other British mammals
  Tuberculosis, 2001
• Global Burden of Tuberculosis
  JAMA, 1999
• Variation in protection by BCG: implications of and for heterologous immunity
  The Lancet, 1995
• Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic
  JAMA, 1995
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
  JAMA, 1994
• Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review
  Tubercle and Lung Disease, 1992
• Recombinant BCG as a candidate oral vaccine vector
  Research in Microbiology, 1990
• Studies on the effect of isoniazid upon the antituberculous immunity induced by BCG vaccination
  Tubercle, 1959